Monogram Health Closes $375M Growth Capital Raise to Support Continued Expansion of Innovative In-Home Kidney and Polychronic Care Model
Summary
Milestone funding from leading strategic and financial investors will help accelerate companys mission to measurably improve outcomes for patients living with polychronic conditions, including chronic kidney and end-stage renal diseaseNASHVILLE, Tenn., Jan. 9, 2023 /PRNewswire/ -- Monogram Health, a value-based specialty provider of in-home evidence-based care and benefit management services for patients living with polychronic conditions, including chronic kidney and end-stage renal disease, today announced it has closed on $375 million of new funding. This milestone growth funding round included investments from leading strategic investors CVS Health, Cigna Ventures, Humana, Memorial Hermann Health System, and SCAN, as well as from both new and existing financial investors including TPG Capital, Frist Cressey Ventures, Heritage Group, Pura Vida Investments, and Norwest Venture Partners, among others.Monogram will use the funding proceeds to continue to support the rapid and widespread deployment of the companys innovative in-home kidney and polychronic care delivery model as well as its technology- driven array of evidence-based clinical services, which include complex case and disease management, utilization management, and medication therapy management. These providers and clinical experts are further bolstered by utilization management teams that focus in and around hospitalizations and discharge management, personalizing the experience and care for Monogram patients in nearly 4,000 U.S. cities across 34 states.With its new strategic syndicate, Monograms investor base now serves over 30% of Medicare Advantage members nationwide and supports upwards of 40% of the U.S. population, uniquely positioning the company to serve those living with chronic kidney disease and their related metabolic disorders. Monogram has made bold strides in offering patients and families enhanced access to much needed health services, while substantially improving the overall affordability of their care. Im proud to work alongside Monograms focused leadership team to continue to propel the company as the sustainable clinical leader for patients across the United States.